2Noutsias M,Pauschinger M,Poller WC,et al.Immuno-modulatory treatment strategies in inflammatory cardio-myopathy,current statue and future perspectives[J].Expert Rev Cardiovasc Ther,2008,2:37.
3Brunetti L,Desantis ER.Treatment of viralmyocarditis caused by coxsackievirus B[J].Am J Health Syst Pharm,2008,65(2):132-137.
4Fohlman J,Pauksen K,Hyypia T,et al.Antiviral treatment with WIN 54 594 reduces mortality in murine coxsackievirus B3 myocarditis[J].Circulation,1996,94(9):2254.
5Ahoot J,Galindo A,Alejos JC,et al.Use of OKT3 for a-cute myocarditis in infrants and children[J].J Heart Lung Transplant,2000,19(11):1118.
6Miyamoto T,Matsumori A,Hwang MW,et al.Therapeutic effects of FTY720,a new immunosuppressive agent,in a murine model of acute viral myocarditis[J].J Am Coll Cardiol,2001,37(6):1713.
7Frustaci A,Chimenti C,Calabrese F,et al.Immunosuppressive therapy for active lymphocyticmyocarditis:Virological and immunologic profile of responders versus nonresponders[J].Circulation,2003,107(6):857-863.
8Thrainsdottir IS,Von BH,Malmberg K,et al.Effect of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure[J].J Cardiovasc Phaemacol,2008,44:101.
